Abbvie Liabilities 2024

Abbvie Liabilities

124.35 B USD

Abbvie Dividend yield

3.25 %

Ticker

ABBV

ISIN

US00287Y1091

WKN

A1J84E

In 2024, Abbvie's total liabilities amounted to 124.35 B USD, a 2.3% difference from the 121.55 B USD total liabilities in the previous year.

Abbvie Aktienanalyse

What does Abbvie do?

Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines. Abbvie ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Abbvie's Liabilities

Abbvie's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Abbvie's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Abbvie's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Abbvie's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Abbvie’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Abbvie Stock

What is the level of liabilities of Abbvie this year?

Abbvie has a debt balance of 124.35 B USD this year.

What were the liabilities of Abbvie compared to the previous year?

The liabilities of Abbvie have increased by 2.3% increased compared to the previous year.

What are the consequences of high debt for investors of Abbvie?

High liabilities can pose a risk for investors of Abbvie, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Abbvie?

Low liabilities mean that Abbvie has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Abbvie affect the company?

An increase in liabilities of Abbvie can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Abbvie affect the company?

A decrease in the liabilities of Abbvie can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Abbvie?

Some factors that can influence the liabilities of Abbvie include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Abbvie so important for investors?

The liabilities of Abbvie are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Abbvie take to modify the liabilities?

To change its liabilities, Abbvie can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Abbvie pay?

Over the past 12 months, Abbvie paid a dividend of 5.92 USD . This corresponds to a dividend yield of about 3.25 %. For the coming 12 months, Abbvie is expected to pay a dividend of 6.04 USD.

What is the dividend yield of Abbvie?

The current dividend yield of Abbvie is 3.25 %.

When does Abbvie pay dividends?

Abbvie pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Abbvie?

Abbvie paid dividends every year for the past 101 years.

What is the dividend of Abbvie?

For the upcoming 12 months, dividends amounting to 6.04 USD are expected. This corresponds to a dividend yield of 3.35 %.

In which sector is Abbvie located?

Abbvie is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbvie kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbvie from 5/15/2024 amounting to 1.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.

When did Abbvie pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Abbvie in the year 2023?

In the year 2023, Abbvie distributed 5.64 USD as dividends.

In which currency does Abbvie pay out the dividend?

The dividends of Abbvie are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Abbvie stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Abbvie

Our stock analysis for Abbvie Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbvie Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.